Catheter Precision (VTAK) Return on Capital Employed (2018 - 2026)
Catheter Precision (VTAK) posted quarterly Return on Capital Employed of 346.78% for Q1 2026, down 29180.0% year-over-year from N/an in Q1 2025, and down 174.88% quarter-over-quarter from 126.16% in Q4 2025.
Catheter Precision (VTAK) Return on Capital Employed (2018 - 2026) Analysis & Trends
Catheter Precision (VTAK) has reported Return on Capital Employed for 9 consecutive years, with 346.78% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Capital Employed fell 29180.0% year-over-year to 346.78%; the TTM figure through Mar 2026 stood at 346.78% (down 29180.0% YoY), while the FY2025 annual figure was 118.06%, down 7646.0% from the prior year.
- Return on Capital Employed fell to 346.78% in Q1 2026 per VTAK's latest filing, from 126.16% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 52.73% in Q1 2024 and bottomed at 346.78% in Q1 2026.
- Historically, Return on Capital Employed has averaged 203.38% across 5 years, with a median of 203.27% in 2023.
- Annual changes were most pronounced in 2024 — Return on Capital Employed surged 25891 bps — and 2026, when it plunged 29180 bps.
- Catheter Precision's Return on Capital Employed stood at 281.5% in 2022, then climbed by 5 bps to 266.33% in 2023, then soared by 80 bps to 52.73% in 2024, then sank by 139 bps to 126.16% in 2025, then sank by 175 bps to 346.78% in 2026.
- Business Quant data shows VTAK's Return on Capital Employed at 346.78% in Q1 2026, 126.16% in Q4 2025, and 191.98% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.08% |
| 10 | Catheter Precision | 564,834.50 | -1.27 Mn | 98,000.00 | -85.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -346.78% |
| Dec 31, 2025 | -126.16% |
| Sep 30, 2025 | -191.98% |
| Jun 30, 2025 | -181.39% |
| Mar 31, 2025 | -54.97% |
| Mar 31, 2024 | -52.73% |
| Dec 31, 2023 | -266.33% |
| Sep 30, 2023 | -260.28% |
| Jun 30, 2023 | -214.56% |
| Mar 31, 2023 | -311.64% |
| Dec 31, 2022 | -281.50% |
| Mar 31, 2022 | -152.21% |
| Dec 31, 2021 | -159.44% |
| Sep 30, 2021 | -128.77% |
| Jun 30, 2021 | -144.71% |
| Mar 31, 2021 | -148.56% |
| Dec 31, 2020 | -116.15% |
| Sep 30, 2020 | -103.58% |
| Jun 30, 2020 | -150.15% |
| Mar 31, 2020 | -147.99% |